Tejuja S, Choudhury S D, Manchanda P K, Malhotra U
Contraception. 1979 Feb;19(2):191-6. doi: 10.1016/s0010-7824(79)80031-1.
The Indian Council of Medical Research conducted a multicentric trial with a single vaginal suppository containing 3 mg 15-Me-PGF2 alpha for terminating pregnancies. Success rate in the 290 women investigated was 79.2 per cent at 30 hours observation. The mean induction-abortion interval was 14.7 hours and the incidence of complete abortions was 58.3 per cent. Vomiting and diarrhoea were the most common side-effects noted. Vomiting was experienced by 72.3 per cent women and diarrhoea by 76.8 per cent. Although the vaginal route for administering 15-Me-PGF2 alpha is simple and the induction-abortion interval short, it is suggested that the combination of a vaginal suppository and prostaglandins intra-muscularly may lead to higher percentage of complete abortions.
印度医学研究理事会开展了一项多中心试验,使用一种含3毫克15-甲基前列腺素F2α的单一阴道栓剂来终止妊娠。在接受调查的290名女性中,30小时观察期时的成功率为79.2%。引产至流产的平均间隔时间为14.7小时,完全流产率为58.3%。呕吐和腹泻是最常见的副作用。72.3%的女性出现呕吐,76.8%的女性出现腹泻。尽管经阴道途径给予15-甲基前列腺素F2α操作简单且引产至流产的间隔时间短,但有人建议阴道栓剂与前列腺素肌肉注射联合使用可能会使完全流产率更高。